Abstract:Key PointsRecently, arrays of clustered, regularly interspaced short palindromic repeats (CRISPRs) have been implicated in a novel genetic interference pathway that limits phage infection and plasmid conjugation. CRISPR loci keep a record of past infections to provide bacteria and archaea with a 'genetic memory' that directs the rejection of invader DNA molecules; therefore these loci constitute an adaptive immune system.CRISPRs (which are approximately 25–50 nucleotides long) are separated by similarly short sequences called spacers that match bacteriophage or plasmid sequences and specify the targets of interference. CRISPR-associated (cas) genes, a set of conserved genes that are associated with these loci, are usually present on one or the other side of the array.CRISPR loci are transcribed as a long precursor that is processed by Cas proteins within the repeat sequences to generate small CRISPR RNAs (crRNAs). The crRNAs serve as guides for target recognition during CRISPR interference. crRNA–Cas ribonucleoprotein complexes seem to generally target invading DNA sequences during interference but may also target RNAs in some species.Upon bacteriophage challenge of a CRISPR-containing bacterial population, mutants resistant to the infection arise through the incorporation of additional spacer sequences derived from the challenging phage. This allows the bacteria to evolve rapidly and adapt to the viruses in the environment.Bacteriophages and plasmids can mobilize foreign genetic material between cells, a process known as horizontal gene transfer (HGT), which is a fundamental source of genetic variability for the evolution of bacteria and archaea. CRISPR interference prevents phage infection and plasmid conjugation and therefore constitutes a natural barrier to HGT. In addition, bacteriophages constantly mutate to evade CRISPR defence. Therefore, CRISPR interference has an important role in the evolution of microbial communities.

Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Diverse viral cas genes antagonize CRISPR immunity

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins

CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Potent Cas9 inhibition in bacterial and human cells by new anti-CRISPR protein families

CRISPR-Cas Controls Cryptic Prophages

Broad-spectrum enzymatic inhibition of CRISPR-Cas12a

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

CRISPR-repressed toxin-antitoxin provides herd immunity against anti-CRISPR elements

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

Disabling Cas9 by an anti-CRISPR DNA mimic

Prophage integration into CRISPR loci enables evasion of antiviral immunity in Streptococcus pyogenes

CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation

Phage anti-CBASS and anti-Pycsar nucleases subvert bacterial immunity

An anti-CRISPR protein disables type V Cas12a by acetylation